Evidence map›Paper›PMID 34360302›Full record

ArticleInternational journal of environmental research and public health2021

Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978-2018 Time Series Analysis in Spain.

Antonio Palazón-Bru, Miriam Calvo-Pérez, Pilar Rico-Ferreira, María Anunciación Freire-Ballesta, Vicente Francisco Gil-Guillén, María de Los Ángeles Carbonell-Torregrosa

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antonio Palazón-BruDepartment of Clinical Medicine, Miguel Hernández University, 03550 Alicante, Spain.ORCID 0000-0002-5959-9631
Miriam Calvo-PérezPrimary Care Pharmacy Service, General University Hospital of Elda, 03600 Alicante, Spain.
Pilar Rico-FerreiraPrimary Care Pharmacy Service, General University Hospital of Elda, 03600 Alicante, Spain.
María Anunciación Freire-BallestaPrimary Care Pharmacy Service, General University Hospital of Alicante, 03010 Alicante, Spain.
Vicente Francisco Gil-GuillénDepartment of Clinical Medicine, Miguel Hernández University, 03550 Alicante, Spain.
María de Los Ángeles Carbonell-TorregrosaDepartment of Clinical Medicine, Miguel Hernández University, 03550 Alicante, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

No studies have evaluated the influence of pharmaceutical copayment on hospital admission rates using time series analysis. Therefore, we aimed to analyze the relationship between hospital admission rates and the influence of the introduction of a pharmaceutical copayment system (PCS). In July 2012, a PCS was implemented in Spain, and we designed a time series analysis (1978-2018) to assess its impact on emergency hospital admissions. Hospital admission rates were estimated between 1978 and 2018 each month using the Hospital Morbidity Survey in Spain (the number of urgent hospital admissions per 100,000 inhabitants). This was conducted for men, women and both and for all-cause, cardiovascular and respiratory hospital discharges. Life expectancy was obtained from the National Institute of Statistics. The copayment variable took a value of 0 before its implementation (pre-PCS: January 1978-June 2012) and 1 after that (post-PCS: July 2012-December 2018). ARIMA (Autoregressive Integrated Moving Average) (2,0,0)(1,0,0) models were estimated with two predictors (life expectancy and copayment implementation). Pharmaceutical copayment did not influence hospital admission rates (with

Indexed as

HospitalizationPharmaceutical PreparationsFemaleHospitalsHumansMaleSpainPharmaceutical Preparationscopaymentcost controlhealth expenditureshospitalizationinpatientspharmacy

Identifiers

PMID34360302
PMCPMC8345418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.